Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Sep 6, 2024; 12(25): 5775-5783
Published online Sep 6, 2024. doi: 10.12998/wjcc.v12.i25.5775
Table 1 Summary of 3 cases of acute macular neuroretinopathy following coronavirus disease 2019 infection
Characteristic
Case 1
Case 2
Case 3
Chief complaintProgressive vision loss in left eye for 2 dBlurring vision in left eye for 10 dSensation of occlusion in right eye for 1 wk
History of present illnessFever for 3 d 1 wk ago, confirmed COVID-19 infection via throat swabFever 2 wk prior, confirmed COVID-19 infection via throat swab, not pregnantConfirmed COVID-19 infection via nucleic acid test 2 wk prior, not pregnant
VaccineInactivated COVID-19 vaccine (Vero cell, Beijing Institute of Biological Products Co., Ltd.)
BCVA0.6 (left eye), 1.0 (right eye)1.0 (right eye), 0.5 (left eye)0.3 (right eye), 1.0 (left eye)
Fundus examRugby ball-like lesion over maculaScattered cotton-wool spots in both eyes
NIRHyporeflective lesion oriented towards fovea in left eyeHyporeflective lesions in both eyes, pronounced in left eye Hyporeflective lesions in right eye
OCT/ OCTAHyporeflective ELM, hyperreflective MZ, diminished EZ; No initial abnormalities in SCP/DCPHyperreflective foci in OPL, hyporeflective foci in EZ/IZ in both eyes, hyperreflective foci in INL in right eyeHyperreflective lesions in OPL, hyporeflective lesions in EZ/IZ, hyperreflective lesions in INL
TreatmentIbuprofen (0.2 g three times a day)Acetaminophen (0.3 g three times a day)Acetaminophen (0.3 g three times a day)
Final diagnosisAMNAMN and PAMMAMN and PAMM